Leadership Transition - Merit Medical Systems, Inc. has appointed Martha Aronson as the new President and CEO, effective October 3, 2025, while Fred P. Lampropoulos will continue as Chairman of the Board until that date [1][2] - Lampropoulos expressed confidence in Aronson's ability to lead the company, highlighting her qualifications and experience in global healthcare [2] - Aronson has a strong background, having held leadership roles at Ecolab, Hill-Rom, and Medtronic, and has served on various boards [2][3] Financial Performance - Merit announced preliminary unaudited revenue for Q2 2025 in the range of approximately $380 to $384 million, representing a projected increase of about 12% to 14% compared to Q2 2024 [5] - The preliminary constant currency revenue for the same period increased by approximately 11% to 13% year-over-year [5] - The impact of foreign exchange on preliminary revenue was a decrease of $2.3 million [12] Company Overview - Founded in 1987, Merit Medical specializes in developing, manufacturing, and distributing proprietary disposable medical devices for various medical procedures [13] - The company serves hospitals globally with a workforce of approximately 7,300 employees [13]

New York, New York, May 22, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered offering (the “Offering”) for its client WORK Medical Technology Group LTD (Nasdaq: WOK) (the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China. Under the ...

Merit Medical (MMSI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.77 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.67%. A quarter ago, it was expected that this maker of disposable medical devices would post earnings of $0.83 per share when it actually produced earnings of $0.93, delivering a surprise of 12.05%.Over the last f ...